CJC-1295 with DAC 20 mg × 1 Vial
Batch-tested · Switzerland
Peptide · Single vial

CJC-1295 with DAC 20 mg × 1 vial.

CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH 1-29) with a drug affinity complex.

Strength
20 mg / vial
Pack
1 vial
Format
Freeze-dried
Research area
Growth hormone

Have this box? Check it's genuine.

Type the six digits from the label.

Have this box? Check it's genuine.

For laboratory research use only. Not for human consumption.

Reference profile
Reference profile

What it is.

CJC-1295 with DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH 1-29) with a drug affinity complex. The DAC lets the peptide bind to albumin in the blood, which gives it a half-life of several days.

Key facts
  • GHRH analogue
  • Drug affinity complex
  • Long-acting

How it is used.

CJC-1295 with DAC is studied in growth hormone research. Studies look at sustained growth hormone and IGF-1 levels and how a long-acting GHRH analogue compares with short-acting ones.

Studied in
  • Growth hormone release
  • GHRH research
  • IGF-1 research
Quality

Tested before it's boxed.

Every batch is made in-house in Switzerland and tested for identity, purity and sterility before it is packed.

How we test
Every batch is tested for
  • Identity LC-MS
  • Content HPLC-UV
  • Purity HPLC-UV
  • Sterility USP <71>
  • Endotoxins USP <85>
  • Particulates USP <788>